Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Journal of Pharmacokinetics and Biopharmaceutics|June 1, 1990
Receptor-mediated prednisolone pharmacodynamics in rats: model verification using a dose-sparing regimenA I Nichols, W J JuskoJournal of Pharmacokinetics and Biopharmaceutics|April 1, 1989
Second generation model for prednisolone pharmacodynamics in the ratA I Nichols, F D Boudinot, W J JuskoThe Journal of Pharmacology and Experimental Therapeutics|September 1, 1989
Pharmacokinetics and pharmacodynamics of prednisolone in obese ratsA I Nichols, R D'Ambrosio, N A Pyszczynski, et al.Journal of Pharmacokinetics and Biopharmaceutics|October 1, 1984
Extended least squares nonlinear regression: a possible solution to the "choice of weights" problem in analysis of individual pharmacokinetic dataC C Peck, S L Beal, L B Sheiner, et al.The Journal of Allergy and Clinical Immunology|August 1, 1985
Clinical pharmacodynamics of theophyllineC C Peck, A I Nichols, J Baker, et al.International Journal of Clinical Pharmacology and Therapeutics|December 24, 2010
The pharmacokinetics and safety of desvenlafaxine in subjects with chronic renal impairmentA I Nichols, L S Richards, J A Behrle, et al.Journal of Pharmaceutical Sciences|February 1, 1985
Disposition and bioavailability of various formulations of tetrahydrocannabinol in the rhesus monkeyE Perlin, C G Smith, A I Nichols, et al.Journal of Clinical Pharmacology|November 1, 1994
Comparative effects of nabumetone, sulindac, and indomethacin on urinary prostaglandin excretion and platelet function in volunteersM I Freed, P R Audet, N Zariffa, et al.Antimicrobial Agents and Chemotherapy|May 1, 1999
Safety and pharmacokinetics of an intramuscular monoclonal antibody (SB 209763) against respiratory syncytial virus (RSV) in infants and young children at risk for severe RSV diseaseH C Meissner, J R Groothuis, W J Rodriguez, et al.Pageof 1